Celltrion Healthcare Placement: Weigh Down from FDA Uncertainty and Placement Overhang
Celltrion Healthcare's shareholder, One Equity Partners, is selling USD 355 million of shares via a secondary placement today. This is the first...
477 Views
Another Negative Sign for Celltrion: Remsima Retail Price Is Falling Too Fast Too Much
Celltrion Healthcare (091990 KS) submitted its 1H18 semi-annual report yesterday. And with this semi-annual report, we finally got to know the...
775 Views
Celltrion (068270): Time Is Not Right for Short Sellers Yet
First, let me tell you this. I'm also a Celltrion basher. I don't like their accounting practices and dual company structure. Not only that,...
375 Views
Celltrion: Manufacturing Risks Remain
Celltrion Inc (068270 KS) continues to struggle with meeting the USFDA's standards for Good Manufacturing Practices. The agency issued a Form 483...
417 Views
Sell Celltrion Inc (068270 KS): Story Unravelling
UPDATE: J&J release Q2 results - 24th July 2018 J&J’s US Remicade sales were flat QoQ. This undermines the story that Celltrion Group is...
487 Views